Insufficient scRNA-seq data for expression of CRHR2 at single-cell level.
Insufficient scRNA-seq data for expression of CRHR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 97% | 142.15 | 633 / 653 | 45% | 1.14 | 275 / 605 |
ovary | 91% | 67.44 | 163 / 180 | 10% | 0.23 | 44 / 430 |
brain | 81% | 151.16 | 2129 / 2642 | 16% | 0.36 | 112 / 705 |
pancreas | 90% | 164.14 | 294 / 328 | 4% | 0.14 | 8 / 178 |
bladder | 86% | 73.43 | 18 / 21 | 8% | 0.18 | 39 / 504 |
breast | 89% | 119.19 | 410 / 459 | 2% | 0.04 | 24 / 1118 |
heart | 89% | 133.03 | 766 / 861 | 0% | 0 | 0 / 0 |
uterus | 84% | 64.61 | 142 / 170 | 3% | 0.08 | 16 / 459 |
esophagus | 80% | 52.62 | 1152 / 1445 | 7% | 0.11 | 13 / 183 |
muscle | 81% | 68.00 | 651 / 803 | 0% | 0 | 0 / 0 |
adipose | 80% | 95.60 | 969 / 1204 | 0% | 0 | 0 / 0 |
intestine | 74% | 44.08 | 715 / 966 | 3% | 0.04 | 15 / 527 |
prostate | 65% | 41.72 | 159 / 245 | 1% | 0.08 | 5 / 502 |
stomach | 52% | 24.54 | 188 / 359 | 5% | 0.07 | 13 / 286 |
skin | 53% | 28.88 | 953 / 1809 | 0% | 0.01 | 2 / 472 |
lung | 35% | 15.82 | 203 / 578 | 16% | 0.65 | 182 / 1155 |
blood vessel | 46% | 27.92 | 610 / 1335 | 0% | 0 | 0 / 0 |
kidney | 15% | 17.45 | 13 / 89 | 16% | 0.38 | 142 / 901 |
adrenal gland | 12% | 4.72 | 30 / 258 | 8% | 0.28 | 19 / 230 |
liver | 4% | 1.00 | 8 / 226 | 4% | 0.09 | 17 / 406 |
spleen | 6% | 1.81 | 15 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 1.20 | 27 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.16 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071376 | Biological process | cellular response to corticotropin-releasing hormone stimulus |
GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0043679 | Cellular component | axon terminus |
GO_0005886 | Cellular component | plasma membrane |
GO_0030425 | Cellular component | dendrite |
GO_0008528 | Molecular function | G protein-coupled peptide receptor activity |
GO_0017046 | Molecular function | peptide hormone binding |
GO_0043404 | Molecular function | corticotropin-releasing hormone receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0015056 | Molecular function | corticotrophin-releasing factor receptor activity |
Gene name | CRHR2 |
Protein name | Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2) CRF2 receptor, beta isoform (Corticotropin releasing hormone receptor 2, isoform CRA_a) Corticotropin releasing hormone receptor 2 CRF2 receptor isoform G (CRH receptor 2 variant B) |
Synonyms | CRH2R hCG_1811942 CRF2R tcag7.680 |
Description | FUNCTION: G-protein coupled receptor for CRH (corticotropin-releasing factor), UCN (urocortin), UCN2 and UCN3. Has high affinity for UCN. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and down-stream effectors, such as adenylate cyclase. Promotes the activation of adenylate cyclase, leading to increased intracellular cAMP levels. |
Accessions | ENST00000348438.8 [Q13324-2] ENST00000471646.6 [Q13324-1] ENST00000506074.6 [Q13324-4] B3SXS9 C9JZM9 ENST00000445981.5 Q99432 A0A090N7T4 ENST00000452278.5 Q13324 ENST00000341843.8 [Q13324-3] F2Z2M6 ENST00000423776.1 |